Literature DB >> 19019741

Mechanism of direct bicarbonate transport by the CFTR anion channel.

Lin Tang1, Mohammad Fatehi, Paul Linsdell.   

Abstract

BACKGROUND: CFTR contributes to HCO(3)(-) transport in epithelial cells both directly (by HCO(3)(-) permeation through the channel) and indirectly (by regulating Cl(-)/HCO(3)(-) exchange proteins). While loss of HCO(3)(-) transport is highly relevant to cystic fibrosis, the relative importance of direct and indirect HCO(3)(-) transport it is currently unknown.
METHODS: Patch clamp recordings from membrane patches excised from cells heterologously expressing wild type and mutant forms of human CFTR were used to isolate directly CFTR-mediated HCO(3)(-) transport and characterize its functional properties.
RESULTS: The permeability of HCO(3)(-) was approximately 25% that of Cl(-) and was invariable under all ionic conditions studied. CFTR-mediated HCO(3)(-) currents were inhibited by open channel blockers DNDS, glibenclamide and suramin, and these inhibitions were affected by mutations within the channel pore. Cystic fibrosis mutations previously associated with disrupted cellular HCO(3)(-) transport did not affect direct HCO(3)(-) permeability.
CONCLUSIONS: Cl(-) and HCO(3)(-) share a common transport pathway in CFTR, and selectivity between Cl(-) and HCO(3)(-) is independent of ionic conditions. The mechanism of transport is therefore effectively identical for both ions. We suggest that mutations in CFTR that cause cystic fibrosis by selectively disrupting HCO(3)(-) transport do not impair direct CFTR-mediated HCO(3)(-) transport, but may predominantly alter CFTR regulation of other HCO(3)(-) transport pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19019741     DOI: 10.1016/j.jcf.2008.10.004

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  34 in total

1.  Initial interrogation, confirmation and fine mapping of modifying genes: STAT3, IL1B and IFNGR1 determine cystic fibrosis disease manifestation.

Authors:  Heike Labenski; Silke Hedtfeld; Tim Becker; Burkhard Tümmler; Frauke Stanke
Journal:  Eur J Hum Genet       Date:  2011-07-06       Impact factor: 4.246

2.  Changes in accessibility of cytoplasmic substances to the pore associated with activation of the cystic fibrosis transmembrane conductance regulator chloride channel.

Authors:  Yassine El Hiani; Paul Linsdell
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

3.  Rescue of epithelial HCO3- secretion in murine intestine by apical membrane expression of the cystic fibrosis transmembrane conductance regulator mutant F508del.

Authors:  Fang Xiao; Junhua Li; Anurag Kumar Singh; Brigitte Riederer; Jiang Wang; Ayesha Sultan; Henry Park; Min Goo Lee; Georg Lamprecht; Bob J Scholte; Hugo R De Jonge; Ursula Seidler
Journal:  J Physiol       Date:  2012-07-16       Impact factor: 5.182

Review 4.  Physicochemical properties of mucus and their impact on transmucosal drug delivery.

Authors:  Jasmim Leal; Hugh D C Smyth; Debadyuti Ghosh
Journal:  Int J Pharm       Date:  2017-09-14       Impact factor: 5.875

Review 5.  Cystic fibrosis transmembrane conductance regulator chloride channel blockers: Pharmacological, biophysical and physiological relevance.

Authors:  Paul Linsdell
Journal:  World J Biol Chem       Date:  2014-02-26

6.  The thiocyanate analog selenocyanate is a more potent antimicrobial pro-drug that also is selectively detoxified by the host.

Authors:  Brian J Day; Preston E Bratcher; Joshua D Chandler; Matthew B Kilgore; Elysia Min; John J LiPuma; Robert J Hondal; David P Nichols
Journal:  Free Radic Biol Med       Date:  2019-11-15       Impact factor: 7.376

Review 7.  Purinergic regulation of duodenal surface pH and ATP concentration: implications for mucosal defence, lipid uptake and cystic fibrosis.

Authors:  J D Kaunitz; Y Akiba
Journal:  Acta Physiol (Oxf)       Date:  2011-01       Impact factor: 6.311

Review 8.  Mechanisms of bicarbonate secretion: lessons from the airways.

Authors:  Robert J Bridges
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

9.  Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.

Authors:  Justin T Marinko; Hui Huang; Wesley D Penn; John A Capra; Jonathan P Schlebach; Charles R Sanders
Journal:  Chem Rev       Date:  2019-01-04       Impact factor: 60.622

10.  Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype.

Authors:  J P Clancy; S G Johnson; S W Yee; E M McDonagh; K E Caudle; T E Klein; M Cannavo; K M Giacomini
Journal:  Clin Pharmacol Ther       Date:  2014-03-05       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.